209 Pre-clinical and translational pharmacology, pharmacokinetics and pharmacodynamics for a humanized anti-OX40 antibody MOXR0916, a T-cell agonist in the treatment of solid tumors
| Autor: | Sukumaran, S., Kim, J.M., Huseni, M., Ruppel, J., Taylor, H., Totpal, K., Zhu, J., Zhang, C., Chiu, H., Stefanich, E.G. |
|---|---|
| Zdroj: | In European Journal of Cancer November 2014 50 Supplement 6:71-71 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|
Full Text from ScienceDirect